FDA Quality Pilot Aims to Streamline Device Review Process

Source: Fierce Biotech

Wednesday, September 13, 2017 | Health Care

The FDA is piloting a new scheme for high-risk medical devices that removes the need for preapproval inspections in return for making more information on device quality available early on, according to a report in FierceBiotech.

The aim is to target the regulator's premarket approval and post-marketing inspections more effectively, and "promote quality in device design and manufacturing," which in turn should reduce device failures and recalls, says the agency in a Federal Register post.

The Premarket Approval Application Critical to Quality (PMA CtQ) pilot is looking for nine device manufacturers willing to collaborate with FDA on identifying the characteristics of a device that are most important for the quality of the product as well as the process used to manufacture it.

Read the full article here.


You must be logged in to leave a comment.